Transverse Myelitis Trial, Recruiting NCT04721717 Sponsor: University of Alabama at Birmingham Condition: Transverse Myelitis
Back to Transverse Myelitis

Transverse Myelitis Trial, Recruiting

NCT04721717
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are 18 years old or older, have some form of paralysis, and live in the community (not in a hospital or care facility)
  • Your paralysis was caused by an injury or accident, or by a condition such as spinal cord injury, head injury, stroke, multiple sclerosis, transverse myelitis, polio, nerve disease, Parkinson's disease, ALS, botulism, or Guillain-Barré syndrome — and this happened after you were a child
  • Your spinal cord injury was not caused by a traumatic event but instead by something like arthritis, cancer, inflammation, infection, or spinal disc problems
  • You are a caregiver for someone living with ALS (also known as Lou Gehrig's disease)
  • You are able to communicate either by speaking or by writing

Who may not be able to join:

  • You have known patterns of harmful behavior, or you are currently experiencing symptoms such as hallucinations, delusions, or serious difficulties with thinking and perception
  • Your paralysis or condition has been present since birth or from early childhood — for example, spina bifida or cerebral palsy

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 September 2020
Est. completion
28 March 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

The Grief and Loss Scale; Emotional Distress - Depression; Perceived Stress Scale; Impact of Events Scale; Meaning and Purpose; Self-Efficacy for Managing Chronic Conditions - Managing Emotions; Sleep Disturbance; Sleep Impact; Ability to Participate in Social Roles and Activities; Satisfaction with Social Roles and Activities; Connor-Davidson Resilience Scale

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov